A significant breakthrough in cancer investigation is occurring with the use of VHH fragments to re-engage mutated p53. This crucial tumor protector protein is frequently disabled in several kinds of malignancies, https://mediajx.com/story304874/mini-antibodies-restore-the-p53-protein-new-promising-approach-for-tumor-treatment